Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. Net Income 2020–2025
Syndax Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Syndax Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -42.7 M, a 49.71% decrease year-over-year.
- Syndax Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -243.2 M.
- Syndax Pharmaceuticals Inc. annual net income for 2025 was -285.4 M, a 10.46% decrease from 2024.
- Syndax Pharmaceuticals Inc. annual net income for 2024 was -318.8 M, a 52.25% increase from 2023.
- Syndax Pharmaceuticals Inc. annual net income for 2023 was -209.4 M, a 40.19% increase from 2022.
- Syndax Pharmaceuticals Inc. annual net income for 2022 was -149.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Syndax Pharmaceuticals Inc. Net Income — FAQ
Syndax Pharmaceuticals Inc. (SNDX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Syndax Pharmaceuticals Inc.'s net income?
Syndax Pharmaceuticals Inc. (SNDX) reported net income of -$285M for fiscal 2025.
Where can I see SNDX's net income history?
The chart and table above show Syndax Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.